<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://acurapharm.com/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/3.1" -->
<!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.2.4" -->
<!-- generated-on="January 24, 2012 2:42 pm" -->
<!-- Debug: Total comment count: 0 -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://acurapharm.com/</loc>
		<lastmod>2012-01-24T14:32:32+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
<!-- Debug: Start Postings -->
	<url>
		<loc>http://acurapharm.com/products/acurox-without-niacin-tablets/</loc>
		<lastmod>2012-01-24T14:41:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/our-business/facilities/</loc>
		<lastmod>2012-01-19T16:56:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/press-releases/</loc>
		<lastmod>2012-01-18T16:23:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/our-business/contacts/</loc>
		<lastmod>2012-01-13T22:05:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/presentations-webcasts/</loc>
		<lastmod>2011-11-23T19:13:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/research-development/</loc>
		<lastmod>2011-11-11T20:45:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/</loc>
		<lastmod>2011-11-07T16:36:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/privacy-policy/</loc>
		<lastmod>2011-11-03T19:20:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/impede-pse/</loc>
		<lastmod>2011-11-02T20:34:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/research-development/impede-technology/</loc>
		<lastmod>2011-11-02T20:27:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/research-development/trademarks/</loc>
		<lastmod>2011-11-02T20:10:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/our-business/commercialization-strategy/</loc>
		<lastmod>2011-11-02T15:06:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/our-business/</loc>
		<lastmod>2011-11-02T14:52:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/sec-filings/</loc>
		<lastmod>2011-10-31T22:22:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/forward-looking-statement/</loc>
		<lastmod>2011-10-31T21:05:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/syringeability-testing/</loc>
		<lastmod>2011-10-21T15:52:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/extraction-testing/</loc>
		<lastmod>2011-10-21T15:50:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-105/</loc>
		<lastmod>2011-10-21T15:47:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-114/</loc>
		<lastmod>2011-10-21T15:46:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-111/</loc>
		<lastmod>2011-10-21T15:44:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-102/</loc>
		<lastmod>2011-10-21T15:41:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-107/</loc>
		<lastmod>2011-10-21T15:40:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-103/</loc>
		<lastmod>2011-10-21T15:38:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-106/</loc>
		<lastmod>2011-10-21T15:36:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-109/</loc>
		<lastmod>2011-10-21T15:35:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-108/</loc>
		<lastmod>2011-10-21T15:34:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-104/</loc>
		<lastmod>2011-10-21T15:33:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-101/</loc>
		<lastmod>2011-10-21T15:31:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/</loc>
		<lastmod>2011-10-21T15:27:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acuracet-tablets/</loc>
		<lastmod>2011-10-21T15:26:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/our-business/markets-for-abuse/</loc>
		<lastmod>2011-10-20T20:40:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/our-business/about-acura/</loc>
		<lastmod>2011-10-20T20:29:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/our-business/management/</loc>
		<lastmod>2011-10-03T20:17:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/vycavert-tablets/</loc>
		<lastmod>2011-09-07T19:12:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/corporate/board-of-directors/</loc>
		<lastmod>2011-08-01T17:13:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/risk-factors/</loc>
		<lastmod>2011-08-01T17:10:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/research-development/aversion-technology/intentional-swallowing/</loc>
		<lastmod>2011-08-01T15:54:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/research-development/aversion-technology/nasal-snorting/</loc>
		<lastmod>2011-08-01T15:53:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/research-development/aversion-technology/intravenous-injection/</loc>
		<lastmod>2011-08-01T15:52:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/research-development/aversion-technology/</loc>
		<lastmod>2011-08-01T15:50:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/public-filings/</loc>
		<lastmod>2011-06-08T14:22:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/corporate/compensation-committee-charter/</loc>
		<lastmod>2009-07-08T19:22:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/terms-of-use/</loc>
		<lastmod>2009-06-29T18:09:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/corporate/</loc>
		<lastmod>2009-06-22T17:33:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/corporate/audit-committee-charter/</loc>
		<lastmod>2009-06-21T20:45:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/corporate/code-of-ethics/</loc>
		<lastmod>2009-06-21T17:36:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/stock-price/</loc>
		<lastmod>2009-06-20T21:31:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/</loc>
		<lastmod>2009-06-20T21:30:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: End Postings -->
<!-- Debug: Start Custom Pages -->
<!-- Debug: End Custom Pages -->
<!-- Debug: Start additional URLs -->
<!-- Debug: End additional URLs -->
</urlset>
